BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,753,481 | -16.8% | 2,411,762 | -5.2% | 0.00% | 0.0% |
Q2 2023 | $41,757,551 | -2.1% | 2,543,091 | -0.3% | 0.00% | 0.0% |
Q1 2023 | $42,636,149 | +9.2% | 2,551,535 | +0.9% | 0.00% | 0.0% |
Q4 2022 | $39,037,622 | -15.0% | 2,529,982 | -17.7% | 0.00% | -20.0% |
Q3 2022 | $45,915,000 | -0.3% | 3,075,391 | +9.8% | 0.01% | 0.0% |
Q2 2022 | $46,038,000 | -24.7% | 2,802,064 | -8.1% | 0.01% | -16.7% |
Q1 2022 | $61,169,000 | -17.1% | 3,049,313 | +4.8% | 0.01% | -14.3% |
Q4 2021 | $73,817,000 | -0.8% | 2,910,769 | +5.5% | 0.01% | -12.5% |
Q3 2021 | $74,436,000 | -5.2% | 2,758,936 | +1.6% | 0.01% | 0.0% |
Q2 2021 | $78,525,000 | +8.4% | 2,715,247 | -1.5% | 0.01% | 0.0% |
Q1 2021 | $72,463,000 | +21.7% | 2,755,232 | +32.6% | 0.01% | 0.0% |
Q4 2020 | $59,522,000 | +36.6% | 2,077,563 | +13.7% | 0.01% | +33.3% |
Q3 2020 | $43,581,000 | +84.6% | 1,827,308 | +61.8% | 0.01% | +50.0% |
Q2 2020 | $23,614,000 | +60.0% | 1,129,338 | +36.9% | 0.00% | +33.3% |
Q1 2020 | $14,761,000 | – | 824,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |